tbuckley/cabot-search huggingface dataset:
Clinical Characteristics Impacting Health-Related Quality of Life in Persons with Von Willebrand Disease
Authors: Shannon L Carpenter, Joanne Wu, Jonathan C. Roberts, Roshni Kulkarni, Peter A. Kouides, Robert F. Sidonio, Jr., Barbara Konkle, Judith Baker, Megan M. Ullman, Randall Curtis, Nicole Crook, Michael B. Nichol
Journal: Blood (2022)
Withaferin-a Alleviates Acute Graft Versus Host Disease By Regulating Immune Cell Proliferation, Differentiation and Cytokine Storm Via Inhibition of JAK2-STAT3 Signalling
Authors: Vikram Gota, Saurabh Kumar Gupta, Deepshikha Dutta, Kajal Dalvi, Twinkle Khanka, Akanksha Chichra, Sachin Punatar, Anant Gokarn, Sumeet Prakash Mirgh, Nishant Jindal, Prashant R. Tembhare, Syed K Khizer Hasan, Lal Hingorani, Navin Khattry
Journal: Blood (2022)
Pegathor Lymphoma, a Phase 2 Study of SAR444245 As a Monotherapy or in Combination with Pembrolizumab for the Treatment of Adults and Adolescents with Relapsed or Refractory B Cell Lymphoma
Authors: Alejandro Berkovits, Eduardo Yanez, Christine Rojas, Raimundo Gazitua, Nicolás Cazap, Anna Sureda, Rao Saleem, Robin Meng, Jing Xu, Michael Streit, Valentine Barboux, Sairah Ahmed
Journal: Blood (2022)
Mutant <i>Asxl1</i> Exacerbates the MPN Phenotype of <i>Calr</i>del52 Mutant Mice with Distinct Effects on Histone H3 Modifications in Megakaryocytes
Authors: Frederike Kramer, Anna E Marneth, Olga Pozdnyakova, Jessica Hem, Malvina Papanastasiou, Andrew Reiter, Steven A Carr, Ann Mullally
Journal: Blood (2022)
Poor Survival Outcomes Among Patients with Burkitt Lymphoma Are Associated with Socioeconomic Disparities
Authors: Oluwasegun Akinyemi, Faith O Abodunrin, Oluwatayo Adeoye, Akinwale Akingbule, Olanrewaju Oni, Bolarinwa Akinwumi, Ademola Ojo, Oluwaseun B Ogunbona, Peter Silberstein
Journal: Blood (2022)
A Comprehensive Reassessment of the Direct DNA Binding Sites of PML-Rara within the Genomes of Primary Hematopoietic Progenitor Cells, and Their Effects on Chromatin Structure and Gene Expression
Authors: Casey D.S. Katerndahl, Olivia R.S. Rogers, Sai Mukund Ramakrishnan, Christopher A Miller, Nichole M Helton, Mieke Hoock, Timothy J Ley
Journal: Blood (2022)
Large Scale Identification and Validation of 85 New HLA Class I-Restricted Minor Histocompatibility Antigens for Immune Monitoring and Modulation after Allogeneic Stem Cell Transplantation
Authors: Kyra J. Fuchs, M. Willy Honders, Marian van de Meent, Indu Khatri, Eva A.S. Koster, Cornelis A.M. van Bergen, Erik B. van den Akker, Constantijn J.M. Halkes, J.H. Frederik Falkenburg, Marieke Griffioen
Journal: Blood (2022)
Take Control. Period. -Interactive Patient Education Website Enhances Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding
Authors: Savannah Norman, Ying Ling, Meffe Filomena, Shamshah Aratia, Deborah Robertson, Aziz Jiwajee, Grace Tang, Paula D. James, Jeff Mosko, Michelle Sholzberg
Journal: Blood (2022)
Ruxolitinib Combined with Dexamethasone in Adult Patients with Newly Diagnosed Hemophagocytic Lymphohistiocytosis: A Prospective, Single-Center, Single-Arm, Phase 2 Clinical Trial
Authors: De Zhou, Xianbo Huang, Xueying Li, Lixia Zhu, Mixue Xie, Xin Huang, Fang Yu, Juying Wei, Liya Ma, Xiudi Yang, Jianai Sun, Li Li, Wanzhuo Xie, Hongyan Tong, Jie Jin, Honghu Zhu, Xiujin Ye
Journal: Blood (2022)
Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with <i>NPM1</i>-Mutated Acute Myeloid Leukemia
Authors: Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W.M. Kühn, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammad Wattad, Katharina Götze, Lars Fransecky, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Mark Ringhoffer, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M. Martens, David Nachbaur, Maisun Abu Samra, Sigrid Machherndl-Spandl, Nadezda Basara, Claudia Leis, Anika Schrade, Silke Kapp-Schwoerer, Lars Bullinger, Felicitas R. Thol, Michael Heuser, Peter Paschka, Verena I. Gaidzik, Maral Saadati, Axel Benner, Richard F. Schlenk, Konstanze Döhner, Arnold Ganser
Journal: Blood (2022)
Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group
Authors: Teresa Calimeri, Sara Steffanoni, Alice Laurenge, Christopher P. Fox, Carole Soussain, Christian Grommes, Maria Chiara Tisi, Jesca Boot, Nicola Crosbie, Carlo Visco, Luca Arcaini, Sridhar Chaganti, Alvaro J. Alencar, Daniele Armiento, Ilaria Romano, Marianna C. Sassone, Jorg Dietrich, Gilad Itchaki, Riccardo Bruna, Nicola S Fracchiolla, Laura Arletti, Adriano Venditti, Stephen Booth, Pellegrino Musto, Khe Hoang-Xuan, Tracy Batchelor, Kate Cwynarski, Andrés J.M. Ferreri
Journal: Blood (2022)
First in Human Study of AUTO4, a TRBC1-Targeting CAR T-Cell Therapy in Relapsed/Refractory TRBC1-Positive Peripheral T-Cell Lymphoma
Authors: Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli, Tobias F. Menne, David A. Irvine, Nivetha Balasubramaniam, Leigh Wood, Justin Shang, Yiyun Zhang, Silvia Basilico, Birgit Huber, Mary Vinson, Koki Lilova, Wolfram Brugger, Martin Pule
Journal: Blood (2022)
Incidentally Detected Complex Karyotypic Abnormalities in the Bone Marrow Provide a Clue to Diagnosing Intravascular Large B-Cell Lymphoma
Authors: Shinpei Harada, Hideki Goto, Hajime Senjo, Keito Suto, Koh Izumiyama, Masayo Yamamoto, Kazuya Sato, Yasutaka Kakinoki, Tomoyuki Saga, Akio Shigematsu, Hiroto Horiguchi, Mutsumi Takahata, Reiki Ogasawara, Satoshi Yamamoto, Keisuke Yamaguchi, Kentaro Wakasa, Tetsuyuki Igarashi, Yoshihito Haseyama, Shinichi Ito, Katsuya Fujimoto, Junichi Hashiguchi, Masao Nakagawa, Takanori Teshima
Journal: Blood (2022)
Immune Markers of Multiple Myeloma Patients Demonstrate Significant Change after Participation in Six-Month Physical Activity Intervention
Authors: Janine M. Joseph, Michaela Hillengass, Hillary Jacobson, Joseph D. Tario, Kristopher Attwood, Adrienne Groman, Rikki Cannioto, Bryan Wittmeyer, Kirsten Moysich, Scott I. Abrams, Jens Hillengass
Journal: Blood (2022)
Tafasitamab and Lenalidomide in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL): Real World Outcomes in a Multicenter Retrospective Study
Authors: David Qualls, Michael J Buege, Phuong Dao, Paolo F. Caimi, Sarah C. Rutherford, Graham Wehmeyer, Jason T. Romancik, Lori A. Leslie, Mwanasha H. Merrill, Jennifer L. Crombie, Behzad Amoozgar, Brad S. Kahl, David A. Bond, Kami J. Maddocks, Michelle Okwali, Venkatraman Seshan, Gilles Salles, Connie Lee Batlevi
Journal: Blood (2022)
Optimal Induction and Consolidation Strategy for Patients with Complex Karyotype and <i>TP53</i>-Mutated Acute Myeloid Leukemia
Authors: Omer H Jamy, Kendall Diebold, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Kelly N. Godby, Donna Salzman, Ravi Bhatia
Journal: Blood (2022)
Patient- and Clinician-Reported Performance Status in Patients with Multiple Myeloma Treated in the United States Using Real World Data
Authors: Vishal Bhatnagar, Bindu Kanapuru, Laura Fernandes, Ting-Yu Chen, Mallorie H. Fiero, Erica Horodniceanu, Nicole Gormley, Catherine Lerro, Fatima Rizvi, Yuan-Li Shen, Felice Yang, Anna Barcellos, Andrew J. Belli, Eric Hansen, Ching-Kun Wang, Donna Rivera, Paul Kluetz
Journal: Blood (2022)
A Murine Model Harboring Cooperating DNMT3A and SF3B1 Mutations Phenocopies SF3B1 Driven Myelodysplastic Syndrome
Authors: Lashanale Wallace, Ana Leal-Cervantes, Amina Metidji, Jacquelyn Myers, Chandra Rolle, Heather Tillman, Esther A. Obeng
Journal: Blood (2022)
Immunosuppressive Monocyte Modulation of CAR T Cell Functions and Impact on Response to CART19
Authors: Kun Yun, Reona Leo Sakemura, Michelle J. Cox, Truc Huynh, Claudia Manriquez-Roman, Olivia Sirpilla, Carli M. Stewart, James H. Girsch, Ekene J. Ogbodo, Ismail Can, Brooke Kimball, Lionel A. Kankeu Fonkoua, Mehrdad Hefazi, Michael W. Ruff, Elizabeth L. Siegler, Mike Mattie, Sao-Mai Nguyen-Mau, Simone Filosto, Saad S. Kenderian
Journal: Blood (2022)
Five-Year Results and Overall Survival Update from the Phase 3 Randomized Study Augment: Lenalidomide Plus Rituximab (R2) Vs Rituximab Plus Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Authors: John P. Leonard, Marek Trneny, Fritz Offner, Jiri Mayer, Huilai Zhang, Grzegorz S. Nowakowski, Phillip Scheinberg, Argyrios Gkasiamis, Joanna Mikita-Geoffroy, Everton Rowe, John G. Gribben
Journal: Blood (2022)
Systematic Functional Characterization for Loss of Function Events Cooperating with TP53 Loss in High-Risk 17p13(del) Multiple Myeloma
Authors: Phaik Ju Teoh, Ricardo De Matos Simoes, Tae-Hoon Chung, Mick Lee, Olga Dashevsky, Shizuka Yamano, Roger Foo, Wee Joo Chng, Constantine S. Mitsiades
Journal: Blood (2022)
Pediatric Evans Syndrome Displays Broad Immune Dysregulation Characterized By Extra-Follicular B-Cell Responses and Unique Autoantibody Repertoire
Authors: Deepak Kumar, Chengyu Prince, Tyler Hulett, Pedro Ramos, Oscar Candelario, Laura Youngblood, Michael Briones, Carolyn Bennett, Shanmuganathan Chandrakasan
Journal: Blood (2022)
The Mutagenic Impact of Radiotherapy in Multiple Myeloma
Authors: Benjamin Diamond, Alexandra M Poos, Bachisio Ziccheddu, Kylee H Maclachlan, Yanming Zhang, Saad Usmani, Eileen M Boyle, Faith E Davies, Gareth J. Morgan, Ola Landgren, Marc S Raab, Francesco Maura, Niels Weinhold
Journal: Blood (2022)
Disrupting the <i>Socs2</i>-Mediated Negative Feedback to JAK-STAT Signaling Boosts Molecular Responses Induced By Interferon-α in a Mouse Model of Myeloproliferative Neoplasms
Authors: Marc Usart, Cédric B. Stoll, Riikka Karjalainen, Hui Hao-Shen, Radek C. Skoda
Journal: Blood (2022)
The Race Is on: BiTE Vs CART As FLT3-Directed Immunotherapies in AML
Authors: Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler, Bettina Brauchle, Florian Märkl, Nora Phillip, Gerulf Hänel, Anetta Marcinek, Maryam Kazerani, Rebecca Goldstein, Michael von Bergwelt, Sebastian Kobold, Veit L Buecklein, Tara Chapman-Arvedson, Marion Subklewe
Journal: Blood (2022)
A Phase 2 Single-Arm Study to Evaluate the Efficacy of Isatuximab, Pomalidomide and Low-Dose Dexamethasone, in Patients with AL Amyloidosis Not in VGPR or Better after Any Previous Therapy (IsAMYP)
Authors: Murielle Roussel, Peter Mollee, Antoine Huart, Hasib Sidiqi, Noemi Horvath, Lionel Karlin, Caroline Jacquet, Pierre Morel, Cecile Leyronnas, Sebastien Bender, Frank Bridoux, Arnaud Jaccard, Simon D. Gibbs
Journal: Blood (2022)
CDK7 Inhibition Targets Proliferative and Metabolic Oncogenic Vulnerabilities in Multiple Myeloma
Authors: Yao Yao, Jessica Fong Ng, Woojun D Park, Mehmet K. Samur, Eugenio Morelli, Nicholas P Kwiatkowski, Jessica Encinas Mayoral, Zuzana Chyra, Yan Xu, Behnam Nabet, Marta Chesi, Nathaniel Gray, Richard A. Young, Kenneth C. Anderson, Charles Y Lin, Nikhil C Munshi, Mariateresa Fulciniti
Journal: Blood (2022)
HZ-a-018 Is a Highly Selective and Potent BTK Inhibitor with CNS-Penetrating Profile for Central Nervous System Lymphoma
Authors: Zhuang Kang, Feng Chen, Yi Lin, Xianggui Yuan, Xi Chen, Wenbin Qian, Haiyan Yang, Miao Hu, Xingguo Liu, Xinglu Zhou, Wenbin Li
Journal: Blood (2022)
Preclinical Development of a CAR-T Cell Approach Targeting the CD84 Antigen Associated to Pediatric Acute Myeloid Leukemia
Authors: Martina Pigazzi, Olivia Marini, Elena Porcù, Giovanni Faggin, Elena Varotto, Paolo Rizzardi, Barbara Buldini, Franco Locatelli, Alessandra Biffi
Journal: Blood (2022)
A First-in-Human Phase I Dose Escalation Study of IMM01, Sirpα Fc Protein in Patients with Relapsed or Refractory Lymphoma
Authors: Junyuan Qi, Mingyuan Sun, Dongmei Ji, Ping Zhou, Shuning Xing, Cheng Huang, Qiying Lu, Wenzhi Tian, Lugui Qiu
Journal: Blood (2022)
Double Hit/Double Expressor Lymphomas: A Multicenter Analysis of Survival Outcomes with CD19-Directed CAR T-Cell Therapy
Authors: Joanna Zurko, Geoffrey Shouse, Pallawi Torka, Tamara K. Moyo, Jason T. Romancik, Imran A. Nizamuddin, Kaitlin Annunzio, Jieqi Liu, Stefan K. Barta, Robert Ferdman, Rahul Bhansali, Jonathon B. Cohen, Sayan Mullick Chowdhury, Nirav N. Shah, Elyse I. Harris, Vaishalee P. Kenkre, McKenzie Sorrell, Brian T. Hess, Deborah M. Stephens, Lindsey A. Fitzgerald, Thomas A. Ollila, Ishan Roy, Shuo Ma, Jane N. Winter, Barbara Pro, Jonathan Moreira, Leo I. Gordon, Alexey V Danilov, Andrew M. Evens, Narendranath Epperla, Reem Karmali
Journal: Blood (2022)
BCL-2 and BCL-XL Antagonists for the Treatment of Relapsed and Refractory Adult Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. a Campus ALL Real-Life Study
Authors: Francesco Malfona, Ilaria Tanasi, Cristina Papayannidis, Vincenzo Federico, Matteo Piccini, Valentina Mancini, Elisa Roncoroni, Elisabetta Todisco, Fabio Giglio, Massimo Gentile, Valentina Gianfelici, Antonino Mulè, Francesco Saraceni, Calogero Vetro, Francesco Zallio, Maria Ilaria Del Principe, Eleonora De Bellis, Robin Foà, Massimiliano Bonifacio, Sabina Chiaretti
Journal: Blood (2022)
MDM2-p53 Inhibitor Alrizomadlin (APG-115) Enhances Antitumor Activity of Pomalidomide in Multiple Myeloma (MM)
Authors: Guangfeng Wang, Eric Liang, Ping Min, Yangfeng Ge, Bingxing Wu, Huidan Yu, Dajun Yang, Yifan Zhai
Journal: Blood (2022)
CRBN Structural Changes, Copy Number Changes and COP9 Signalosome Subunits Gene Expression Mediate Sensitivity to New Celmod Compound CC-92480 in Multiple Myeloma Patients
Authors: Remi Tilmont, Ranjan Maity, Noemie Leblay, Holly Lee, Elie Barakat, Paola Neri, Nizar J. Bahlis
Journal: Blood (2022)
CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL
Authors: Ranjit Nair, Amy Ayers, Loretta J. Nastoupil, Jillian R. Gunther, Luis Fayad, Nathan H. Fowler, Roberto N. Miranda, Fredrick B. Hagemeister, Hun Ju Lee, Maria Alma Rodriguez, Raphael Steiner, Paolo Strati, Yago Nieto, Jeremy L. Ramdial, Dai Chihara, Michael L. Wang, Luis E Malpica Castillo, Neeraj Saini, Preetesh Jain, Chelsea C. Pinnix, Bouthaina S. Dabaja, Michael R Green, Christopher R. Flowers, L. Jeffrey Medeiros, Mario L. Marques-Piubelli, Francisco Vega, Mansoor Noorani, Sairah Ahmed, Jason Westin, Sattva S. Neelapu, Lei Feng, Swaminathan Padmanabhan Iyer
Journal: Blood (2022)
Reproduktiv Patterns Among Non-Hodgkin Lymphoma Survivors By Subtype in Sweden, Denmark and Norway
Authors: Joshua P.P. Entrop, Caroline E. Weibull, Karin E. Smedby, Lasse Hjort Jakobsen, Andreas K. Oevlisen, Ingrid Glimelius, Anna Marklund, Thomas S. Larsen, Harald Holte, Alexander Fosså, Knut B. Smeland, Tarec Christoffer Christoffer El-Galaly, Sandra Eloranta
Journal: Blood (2022)
Optimized Method for Cell Surface Protein Identification on Primary B-Cell Precursor Acute Lymphoblastic Leukemia Cells
Authors: Katsiaryna Marhelava, Klaudyna Fidyt, Agata Malinowska, Bianka Swiderska, Monika Pepek, Agata Karolina Pastorczak, Agnieszka Kraft, Magdalena Winiarska, Malgorzata Firczuk
Journal: Blood (2022)
Prognostic Importance of Cytogenetic Subgroups in Relapse Risk Stratification in Children and Young Adults with First Relapsed B-ALL: A Children's Oncology Group Study AALL1331
Authors: Teena Bhatla, Laura Hogan, Xinxin Xu, Lingyun Ji, Andrew J. Carroll, Nyla A. Heerema, Mary Shago, Lia Gore, James A. Whitlock, Stephen P. Hunger, Mignon L. Loh, Patrick A. Brown
Journal: Blood (2022)
Dysregulated Humoral and Cellular Response to Sars-Cov-2 Vaccination in Patients with MGUS and SMM
Authors: Yoshinobu Konishi, Romanos Sklavenitis-Pistofidis, Michelle P. Aranha, Ting Wu, Hong Yue, Elizabeth D. Lightbody, Mahshid Rahmat, Michael Timonian, Shohreh Varmeh, Daniel Heilpern-Mallory, Michael P. Agius, Nang Kham Su, Jacqueline Perry, Erica Horowitz, Maya I. Davis, Anna V. Justis, Radoslaw P. Nowak, Mark Hamilton, Daniel Auclair, Catherine R. Marinac, Eric S. Fischer, Gad Getz, Irene Ghobrial
Journal: Blood (2022)
Myeloma Developing Regimens Using Genomics (MyDRUG): Longitudinal Single-Cell Transcriptional Landscape of the Myeloma and Immune Microenvironment in Relapsed/Refractory Multiple Myeloma Patients Treated with MEK-Inhibitor, Cobimetinib
Authors: Reyka G. Jayasinghe, George Mulligan, April Cook, Mark Hamilton, Sacha Gnjatic, Seunghee Kim-Schulze, Hearn J. Cho, Shaji K Kumar
Journal: Blood (2022)
Incidence of Ischemic Stroke Has Increased in Californians with Sickle Cell Disease in the Post-STOP Era
Authors: Olubusola Oluwole, Ann M Brunson, Oyebimpe O. Adesina, Shaina M Willen, Theresa H.M. Keegan, Kleber Yotsumoto Fertrin, Ted Wun
Journal: Blood (2022)
C-MYC Targeting By Degradation: Novel Dual c-Myc/GSPT1 Degrader GT19715 Induces <i>TP53</i>-Independent Cell Death in Acute Myeloid Leukemia and Lymphomas
Authors: Yuki Nishida, Darah A Scruggs, Edward Ayoub, Tallie Patsilevas, Vivian Ruvolo, Po Yee Mak, Bing Z Carter, Steffen Boettcher, Abhishek Maiti, Qianxiang Zhou, Zhaohui Yang, Honghua Yan, Liandong Ma, Michael Andreeff
Journal: Blood (2022)
Real-World Outcomes with Ibrutinib in Patients with Chronic Lymphocytic Leukemia: Impact of Patient Typology on Adherence and Retention Rates within the German REALITY Study
Authors: Manfred Welslau, Sjaak Bloem, Rudolf Schlag, Steffen Dörfel, Sabrina Buchholz, Lukas Vornholz, Holger Schulz, Anke Gerhardt
Journal: Blood (2022)
Measurable Residual Disease Guided Therapy in Intermediate-Risk AML Patients Compared to an Unguided Cohort Using Propensity Score Matching
Authors: Jesse M. Tettero, Lok Lam Ngai, Costa Bachas, Dimitri A. Breems, Thomas Fischer, Bjørn Tore Gjertsen, Patrycja Gradowska, Laimonas Griskevicius, Jeroen J.W.M. Janssen, Gunnar Juliusson, Johan A. Maertens, Markus G Manz, Thomas Pabst, Jakob Passweg, Kimmo Porkka, Peter JM Valk, Bob Lowenberg, Gert J. Ossenkoppele, Jacqueline Cloos
Journal: Blood (2022)
Oncogenic Mutational Disruption of KLHL6 Dimers Fuels B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma
Authors: Leo Meriranta, Selma Sorri, Sadia Zafar, Xiaonan Liu, Eerika Sahlberg, Olli Dufva, Helka Göös, Marja-Liisa Karjalainen-Lindsberg, Markku Varjosalo, Marko Hyytiäinen, Sirpa Leppa
Journal: Blood (2022)
A FVIII-Mimetic Bispecific Antibody with an Embedded Self-Regulation Mechanism Reduces the Risk of Prothrombotic Events for the Treatment of Haemophilia a
Authors: Vincent Muczynski, Angel Smith, Thibaud Sefiane, Olivier D. Christophe, Peter J. Lenting, David Granger, Kerry Chester, Amit C. Nathwani
Journal: Blood (2022)
Prognostic Impact of <i>CEBPA</i> bZIP Domain Mutation in Cytogenetically Normal Acute Myeloid Leukemia
Authors: Naoki Miyashita, Masahiro Onozawa, Shota Yoshida, Hiroyuki Kimura, Shogo Takahashi, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Shinichi Fujisawa, Akio Mori, Shuichi Ota, Yasutaka Kakinoki, Yutaka Tsutsumi, Satoshi Yamamoto, Takuto Miyagishima, Takahiro Nagashima, Makoto Ibata, Hajime Kobayashi, Yoshihito Haseyama, Katsuya Fujimoto, Toshimichi Ishihara, Hajime Sakai, Takeshi Kondo, Takanori Teshima
Journal: Blood (2022)
Post-Transplant Cyclophosphamide Associated with Increased Early Mixed Donor Chimerism in Myeloid Malignancies; A Single-Center Experience
Authors: Fieke W. Hoff, Prapti A. Patel, Stephen S. Chung, Naveen Premnath, Jude Khatib, Mirjana Tadic-Ovcina, Abeer AhmedRabie, Debra Helton, Jaime Shahan, Courtney Dryden, Hetalkumari Patel, Afrough Aimaz, Praveen Ramakrishnan Geethakumari, Robert H. Collins, Madhuri Vusirikala, Yazan F. Madanat
Journal: Blood (2022)
Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: Real World Experience in Latin America. A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)
Authors: Myrna Candelaria, Luis Villela, Marialejandra Alejandra Torres Viera, Camila Peña, Macarena Roa, Daniela Zambrano, Perla R.R. Colunga-Pedraza, Arianna Robles-Rodriguez, Fernando Pérez-Jacobo, Ana Carolina Oliver, María Victoria Irigoín, Rosio Baena, Henry Idrobo, Sally Rose Paredes, Rosa Oliday, Denisse Castro, Efreen Montaño Figueroa, Guilherme Fleury Perini, Luis Enrique Malpica Castillo, Brady E Beltran, Jorge J. Castillo
Journal: Blood (2022)
Tumor-Immune Architecture and the Regulation of Antigen-Specific T-Cell Infiltration in Multiple Myeloma and Premalignant Plasma Cell Disorders
Authors: Hope Robinson, Nancy Villa, David L Jaye, Ajay K. Nooka, Alyssa Duffy, Samuel McCachren, Julia Manalo, Jeffrey M. Switchenko, Ava Horvat, Vaunita C Parihar, Jingjing Gong, Yan Liang, Geoffrey Smith, Vikas A Gupta, Lawrence H. Boise, Jonathan L. Kaufman, Craig C Hofmeister, Nisha Joseph, Sagar Lonial, Kavita Dhodapkar, Madhav Dhodapkar
Journal: Blood (2022)
Flap Structure-Specific Endonuclease 1 Coordinates with a Helicase (ASCC3) to Drive Genomic Instability, Proliferation and Poor Clinical Outcome in Myeloma
Authors: Chengcheng Liao, Srikanth Talluri, Shidai Mu, Subodh Kumar, Lakshmi B. Potluri, Jialan Shi, Leutz Buon, Masood A. Shammas, Nikhil C Munshi
Journal: Blood (2022)
Clinical Efficacy Observation of Humanized BCMA-CAR-T in the Treatment of Relapsed/Refractory Multiple Myeloma Complicated with Extramedullary Lesions
Authors: Yi Wang, Hui Wang, Ben Niu, Ying Gao, Ding Zhang, Yudi Miao, Wei Zhou, Limin Hou, Hong Zhang, Xingxing Hu, Fangyuan Wang, Lan Li, Xingli Ru, Weihua Zhang, Xiang Li, Feng Guan
Journal: Blood (2022)
Heightened Endoplasmic-Reticulum Stress Is a Targetable Vulnerability of Malignant Plasma Cells in Multiple Myeloma
Authors: Danai Dima, Metis Hasipek, Divya Jyoti Singh, Dongxu Jiang, Anand D. Tiwari, Dale Grabowski, Yvonne Parker, Daniel J. Lindner, Jianjun Zhao, Kenneth H. Shain, Jack Khouri, Jaroslaw P. Maciejewski, Babal K. Jha
Journal: Blood (2022)
Patient Derived Xenografts Highlight Mouse-Specific Tumor Evolution Patterns and Genomic Diversity of Multiple Myeloma
Authors: Nathan Becker, Enze Liu, Parvathi Sudha, Aneta Mikulasova, Travis S Johnson, Attaya Suvannasankha, Mohammad Issam Abu Zaid, Rafat Abonour, Brian A. Walker
Journal: Blood (2022)
Targeting CD38 in T-ALL Upregulates the Targetable Polyamine Metabolism Pathway
Authors: Caroline Diorio, Tiffaney L. Vincent, Tori Fuller, Rawan Shraim, Tina Glisovic-Aplenc, Theresa Ryan, Kimberly Veliz, Haley Newman, Gerald Wertheim, Hamid Bassiri, Annette Vu, Michael Hogarty, Carl H June, Stephan A. Grupp, Sarah K Tasian, Richard Aplenc, Saar Gill, David T. Teachey
Journal: Blood (2022)
Broadly Applicable TCR Based Therapy for Multiple Myeloma Targeting the Jchain
Authors: Miranda H. Meeuwsen, Anne K. Wouters, Tassilo L.A. Wachsmann, Renate S. Hagedoorn, Michel G.D. Kester, Dennis F.G. Remst, Dirk M. van der Steen, Arnoud H. de Ru, Els P. van Hees, Marieke Griffioen, Peter A. van Veelen, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk
Journal: Blood (2022)
Cardiac and Vascular Risks Are the Essential Parameters for Long-Term Surveillance of Lower Risk Childhood Acute Leukemia Survivors
Authors: Paul Saultier, Nour El Riachy, Yves Bertrand, Marie-Dominique Tabone, Guy Leverger, Jean-Hugues Dalle, Andre Baruchel, Cecile Pochon, Catherine Paillard, Stephane Ducassou, Marilyne Poiree, Dominique Plantaz, Justyna Kanold, Virginie Gandemer, Nicolas Sirvent, Genevieve Plat, Isabelle Pellier, Yves Reguerre, Sandrine Thouvenin, Audrey Françoise Petit, Pascal Auquier, Julie Berbis, Gerard Michel
Journal: Blood (2022)
Targeting Autophagy to Overcome Resistance to Immunogenic Chemotherapy in High-Risk Multiple Myeloma
Authors: Annamaria Gulla, Eugenio Morelli, Mehmet K. Samur, Megan Johnstone, Cirino Botta, Delaney Vinaixa, Marcello Turi, Mariateresa Fulciniti, Kenneth Wen, Selma Cifric, Srikanth Talluri, Giada Bianchi, Rao Prabhala, Paul G. Richardson, Dharminder Chauhan, Ruben D. Carrasco, Teru Hideshima, Nikhil C Munshi, Kenneth C. Anderson
Journal: Blood (2022)
Prospective Analysis to Determine Barriers to Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed and Relapsed Acute Leukemia
Authors: Karthik Nath, Jasme Lee, Theresa A Elko, Lauren Levy, Elaina Preston, Sean M. Devlin, Doris M Ponce, Richard J. Lin, Brian C. Shaffer, Christina Cho, Ioannis Politikos, Ann A Jakubowski, Jae H Park, Raajit Rampal, Miguel-Angel Perales, Martin S. Tallman, Juliet N. Barker, Sergio A Giralt, Ellin Berman, Roni Tamari, Eytan Stein, Boglarka Gyurkocza
Journal: Blood (2022)